ATIC
Summary: This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | MIM:601731 | Ensembl:ENSG00000138363 | HGNC:HGNC:794 | PA25094 | 2q35 |
Gene Categories:
DRUGGABLE GENOMEGO terms in ATIC
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | TAS | GO:0003937 | IMP cyclohydrolase activity |
| MF | TAS | GO:0004643 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity |
| MF | IPI | GO:0042803 | protein homodimerization activity |
| MF | HDA | GO:0045296 | cadherin binding |
| BP | IEA | GO:0003360 | brainstem development |
| BP | TAS | GO:0006139 | nucleobase-containing compound metabolic process |
| BP | IEA | GO:0006189 | 'de novo' IMP biosynthetic process |
| BP | IEA | GO:0009116 | nucleoside metabolic process |
| BP | TAS | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process |
| BP | IEA | GO:0010035 | response to inorganic substance |
| BP | IEA | GO:0021549 | cerebellum development |
| BP | IEA | GO:0021987 | cerebral cortex development |
| BP | IEA | GO:0031100 | animal organ regeneration |
| BP | IEA | GO:0046452 | dihydrofolate metabolic process |
| BP | IEA | GO:0046654 | tetrahydrofolate biosynthetic process |
| CC | IDA | GO:0005829 | cytosol |
| CC | TAS | GO:0005829 | cytosol |
| CC | IDA | GO:0005886 | plasma membrane |
| CC | HDA | GO:0016020 | membrane |
| CC | HDA | GO:0070062 | extracellular exosome |
Gene expression in normal tissue: ATIC
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ATIC
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1430728 | Metabolism |
| reactome | R-HSA-15869 | Metabolism of nucleotides |
| reactome | R-HSA-73817 | Purine ribonucleoside monophosphate biosynthesis |
| reactome | R-HSA-8956320 | Nucleobase biosynthesis |
| humancyc | PWY-6124 | inosine-5,-phosphate biosynthesis |
| humancyc | PWY-841 | purine nucleotides de novo biosynthesis |
| pharmgkb | PA165291575 | Antimetabolite Pathway - Folate Cycle, Pharmacodynamics |
| pharmgkb | PA2039 | Methotrexate Pathway (Cancer Cell), Pharmacodynamics |
| kegg | hsa00230 | Purine metabolism - Homo sapiens (human) |
| kegg | hsa00670 | One carbon pool by folate - Homo sapiens (human) |
| smpdb | SMP00050 | Purine Metabolism |
| smpdb | SMP00144 | Adenosine Deaminase Deficiency |
| smpdb | SMP00167 | Adenylosuccinate Lyase Deficiency |
| smpdb | SMP00168 | AICA-Ribosiduria |
| smpdb | SMP00203 | Molybdenum Cofactor Deficiency |
| smpdb | SMP00210 | Purine Nucleoside Phosphorylase Deficiency |
| smpdb | SMP00220 | Xanthine Dehydrogenase Deficiency (Xanthinuria) |
| smpdb | SMP00364 | Lesch-Nyhan Syndrome (LNS) |
| smpdb | SMP00365 | Gout or Kelley-Seegmiller Syndrome |
| smpdb | SMP00427 | Azathioprine Action Pathway |
| smpdb | SMP00428 | Mercaptopurine Action Pathway |
| smpdb | SMP00430 | Thioguanine Action Pathway |
| smpdb | SMP00512 | Xanthinuria type I |
| smpdb | SMP00513 | Xanthinuria type II |
| smpdb | SMP00535 | Adenine phosphoribosyltransferase deficiency (APRT) |
| smpdb | SMP00536 | Mitochondrial DNA depletion syndrome |
| smpdb | SMP00537 | Myoadenylate deaminase deficiency |
| wikipathways | WP241 | One Carbon Metabolism |
| wikipathways | WP4224 | Purine metabolism |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD263 | AACOCF3 | 4 |
| iGMDRD399 | Selumetinib | 3 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD562 | Navitoclax | 3 |
| iGMDRD782 | DC-45-A2 | 3 |
| iGMDRD289 | Parthenolide | 7 |
| iGMDRD121 | GMX1778 | 2 |
| iGMDRD474 | Avrainvillamide | 1 |
| iGMDRD138 | PX 12 | 3 |
| iGMDRD103 | SN-38 | 3 |
| iGMDRD255 | SB225002 | 2 |
| iGMDRD123 | Isoevodiamine | 3 |
| iGMDRD466 | Chaetocin | 2 |
| iGMDRD945 | ML214 | 4 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD427 | ABT737 | 3 |
| iGMDRD701 | NVP-AUY922 | 3 |
| iGMDRD483 | SCH-529074 | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ATIC

